DiagnoCure Oncology Gains CLIA Certification for Colorectal Cancer Test | GenomeWeb
NEW YORK (GenomeWeb News) – DiagnoCure Oncology Laboratories said today that its colorectal cancer staging test has been certified for marketing in the US by the Center for Medicare and Medicaid Services under the Clinical Laboratory Improvement Amendments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.